+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Esomeprazole Magnesium Enteric-coated Tablets Market - Global Forecast 2026-2032- Product Image
Esomeprazole Magnesium Enteric-coated Tablets Market - Global Forecast 2026-2032- Product Image
Sale

Esomeprazole Magnesium Enteric-coated Tablets Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6141095
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Esomeprazole Magnesium Enteric-coated Tablets Market is projected to reach USD 444.77 Million in 2026. It is expected to continue growing at a CAGR of 10.63%, reaching USD 798.36 Million by 2032.

Esomeprazole Magnesium Enteric-Coated Tablets: Executive Overview

Esomeprazole magnesium enteric-coated tablets are oral proton pump inhibitor medicines designed to reduce gastric acid secretion. Their enteric coating helps protect the active ingredient from degradation in the stomach and supports delivery to the small intestine. Clinical use commonly includes acid-related disorders such as gastroesophageal reflux disease, erosive esophagitis, and selected ulcer-management regimens, subject to local authorization, prescribing information, and professional guidance.

Shifting Treatment Pathways and Formulation Priorities

The treatment landscape is being shaped by greater attention to appropriate acid-suppression use, adherence, medication review, and patient-specific risk assessment. Enteric-coated tablet formats remain relevant where oral administration is suitable, while healthcare systems increasingly emphasize clear indications, appropriate duration, deprescribing when clinically justified, and avoidance of unnecessary polypharmacy. Manufacturing priorities include dosage consistency, coating performance, stability, packaging integrity, and reliable supply of active pharmaceutical ingredients and finished products.

Artificial Intelligence Strengthens Evidence, Quality, and Patient Support

Artificial intelligence can support this product area through pharmacovigilance signal detection, automated review of scientific and regulatory documents, demand and inventory analytics, and identification of potential quality deviations. In clinical workflows, decision-support tools may help reconcile medicines, flag interaction or duplication risks, and personalize adherence interventions. These applications require validated datasets, human oversight, transparent governance, privacy safeguards, and controls against automation bias; AI should complement rather than replace prescribing judgment and regulatory accountability.

Regional Insights Across Six Healthcare Environments

North America combines mature clinical guidance, regulated pharmacy channels, and strong scrutiny of long-term proton pump inhibitor use. Europe emphasizes harmonized quality expectations alongside national reimbursement and prescribing policies. Asia-Pacific includes highly varied regulatory systems, manufacturing capabilities, and access conditions, creating differing pathways for branded, generic, hospital, and retail supply. Latin America is characterized by diverse public-private healthcare structures and uneven access across countries. The Middle East shows varied procurement models and a strong role for centralized institutions in several markets, while Africa’s requirements are closely linked to affordability, essential-medicine availability, distribution reliability, and diagnostic capacity.

Group-Level Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN presents a mix of regulatory harmonization efforts, private retail channels, and differing national access conditions. BRICS members reflect substantial variation in domestic pharmaceutical production, public procurement, and regulatory implementation. The European Union benefits from shared regulatory structures while retaining national differences in reimbursement and prescribing practice. G7 systems generally place strong emphasis on evidence standards, pharmacovigilance, and stewardship of acid-suppressing therapy. GCC countries often combine centralized procurement with private-sector distribution, whereas NATO membership spans distinct health systems; defense-related medical supply considerations may matter in some settings but do not replace national civil-health requirements.

Country-Level Considerations for Access and Use

Australia and Canada operate within mature regulatory and reimbursement frameworks, with attention to appropriate prescribing and pharmacy access. Brazil, Mexico, and India require navigation of diverse public and private channels, regional access differences, and local regulatory requirements. China, Japan, and South Korea combine sophisticated healthcare infrastructure with distinct approval, reimbursement, and clinical-practice systems. France, Germany, Italy, Spain, and the United Kingdom place significant weight on evidence, safety monitoring, and national or regional health-system policies. Russia’s pharmaceutical environment requires country-specific regulatory, procurement, logistics, and compliance assessment. Across all listed countries, product labeling, prescription status, quality standards, and treatment guidance should be verified locally.

Actions for Leaders: Strengthen Quality, Stewardship, and Access

Industry leaders should maintain robust control of active-ingredient sourcing, coating performance, dissolution, stability, serialization where applicable, and complaint handling. They should align medical and commercial activities with approved indications, provide clear education on administration and duration, and support responsible deprescribing conversations through healthcare professionals. Portfolio and supply decisions should account for public procurement, pharmacy distribution, local registration, and contingency planning. Digital and AI investments should begin with narrowly defined, measurable use cases governed by validation, cybersecurity, privacy, and human review. Ongoing monitoring of safety communications, guideline changes, and country-specific requirements is essential.

Methodology: Structured Review of Product, Clinical, and Regulatory Factors

This executive summary uses a qualitative synthesis framework focused on the dosage form, therapeutic role, healthcare delivery context, and operating requirements of esomeprazole magnesium enteric-coated tablets. The assessment organizes considerations by region, multinational group, and country, and examines formulation quality, clinical stewardship, access pathways, supply resilience, pharmacovigilance, and responsible technology adoption. No market estimates, market sizing, market shares, forecasts, or company-specific claims are used. Country-level conclusions are directional and should be validated against current local labels, formularies, regulatory notices, treatment guidelines, and procurement rules.

Conclusion: Responsible Delivery Remains the Core Differentiator

Esomeprazole magnesium enteric-coated tablets occupy an established role in acid-related disease management, but successful delivery depends on more than formulation availability. Consistent quality, appropriate patient selection, adherence support, duration review, pharmacovigilance, and resilient distribution are central priorities across diverse healthcare systems. Regional and country differences require localized regulatory and access strategies, while artificial intelligence can improve oversight when implemented with evidence, accountability, and human control.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Esomeprazole Magnesium Enteric-coated Tablets Market, by Route Of Administration
7.1. Introduction
7.2. Intravenous
7.3. Oral
8. Esomeprazole Magnesium Enteric-coated Tablets Market, by Dosage Strength
8.1. Introduction
8.2. 10 Mg
8.3. 20 Mg
8.4. 40 Mg
9. Esomeprazole Magnesium Enteric-coated Tablets Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.3. Tablet
10. Esomeprazole Magnesium Enteric-coated Tablets Market, by Application
10.1. Introduction
10.2. Gastroesophageal Reflux Disease
10.2.1. Erosive
10.2.2. Non Erosive
10.3. Peptic Ulcer Disease
10.3.1. Duodenal Ulcer
10.3.2. Gastric Ulcer
10.4. Zollinger Ellison Syndrome
11. Esomeprazole Magnesium Enteric-coated Tablets Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.2.1. Private Hospital
11.2.2. Public Hospital
11.3. Online Pharmacy
11.3.1. E Commerce Platforms
11.3.2. Telepharmacy
11.4. Retail Pharmacy
11.4.1. Chain Pharmacy
11.4.2. Independent Pharmacy
12. Esomeprazole Magnesium Enteric-coated Tablets Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Esomeprazole Magnesium Enteric-coated Tablets Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Esomeprazole Magnesium Enteric-coated Tablets Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alkem Laboratories Ltd.
16.2. Amneal Pharmaceuticals LLC
16.3. AstraZeneca PLC
16.4. Aurobindo Pharma Ltd.
16.5. Cadila Pharmaceuticals Ltd. (Zydus Cadila)
16.6. Cipla Ltd.
16.7. Dr. Reddy’s Laboratories Ltd.
16.8. Glenmark Pharmaceuticals Ltd.
16.9. Lupin Limited
16.10. Sun Pharmaceutical Industries Ltd.
16.11. Teva Pharmaceutical Industries Ltd.
16.12. Torrent Pharmaceuticals Ltd.
16.13. Viatris Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Esomeprazole Magnesium Enteric-coated Tablets Market, Years Considered for the Study
FIGURE 2. Global Esomeprazole Magnesium Enteric-coated Tablets Market, Research Design
FIGURE 3. Global Esomeprazole Magnesium Enteric-coated Tablets Market, Research Framework
FIGURE 4. Global Esomeprazole Magnesium Enteric-coated Tablets Market, Data Triangulation
FIGURE 5. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 7. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 9. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 11. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Esomeprazole Magnesium Enteric-coated Tablets Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Esomeprazole Magnesium Enteric-coated Tablets Market Segmentation & Coverage
TABLE 2. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
TABLE 3. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 4. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 11. Global 10 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global 10 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global 10 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global 20 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global 20 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global 20 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global 40 Mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global 40 Mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global 40 Mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 21. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 28. Global Gastroesophageal Reflux Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Gastroesophageal Reflux Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Gastroesophageal Reflux Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Erosive Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Erosive Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Erosive Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Non Erosive Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Non Erosive Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Non Erosive Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Peptic Ulcer Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Peptic Ulcer Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Peptic Ulcer Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Duodenal Ulcer Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Duodenal Ulcer Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Duodenal Ulcer Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Gastric Ulcer Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Gastric Ulcer Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Gastric Ulcer Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Zollinger Ellison Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Zollinger Ellison Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Zollinger Ellison Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 50. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global E Commerce Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global E Commerce Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global E Commerce Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Telepharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Telepharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Telepharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Chain Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Chain Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Chain Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Independent Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Independent Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Independent Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 89. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 91. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 92. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 93. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 95. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 96. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 98. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 99. North America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 100. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 102. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 103. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 104. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 106. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 107. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 109. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 110. Latin America Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 111. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 113. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 114. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 115. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 117. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 118. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 119. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 120. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 121. Europe Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 122. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 124. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 125. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 126. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 128. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 129. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 131. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 132. Middle East Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 133. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 135. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 136. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 137. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 139. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 140. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 142. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 143. Africa Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 144. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 147. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 148. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 149. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 151. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 152. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 154. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 155. ASEAN Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 156. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 158. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 159. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 160. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 162. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 163. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 165. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 166. GCC Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 167. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 169. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 170. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 171. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 173. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 174. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 176. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 177. European Union Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 178. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 180. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 181. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 182. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 184. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 185. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 187. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 188. BRICS Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 189. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 191. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 192. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 193. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 195. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 196. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 198. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 199. G7 Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 200. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 202. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 203. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 204. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 206. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 207. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 209. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 210. NATO Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 211. Global Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 212. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
TABLE 213. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 214. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 215. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 216. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 218. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 219. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 221. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 222. United States Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 223. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
TABLE 224. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 225. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 226. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 227. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 229. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 230. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 231. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 232. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 233. Canada Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 234. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
TABLE 235. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 236. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 237. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 238. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 240. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 241. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 243. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 244. Mexico Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 245. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
TABLE 246. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 247. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 248. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 249. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 251. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 252. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 254. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 255. Brazil Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 256. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
TABLE 257. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 258. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 259. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 260. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 262. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 263. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 265. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 266. United Kingdom Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 267. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
TABLE 268. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 269. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 270. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 271. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 273. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 274. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 276. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 277. Germany Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 278. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
TABLE 279. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 280. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 281. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 282. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Gastroesophageal Reflux Disease, 2017-2032 (USD Million)
TABLE 284. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Peptic Ulcer Disease, 2017-2032 (USD Million)
TABLE 285. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 286. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Hospital Pharmacy, 2017-2032 (USD Million)
TABLE 287. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Online Pharmacy, 2017-2032 (USD Million)
TABLE 288. France Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Retail Pharmacy, 2017-2032 (USD Million)
TABLE 289. Russia Esomeprazole Magnesium Enteric-coated Tablets Market Size, 2017-2032 (USD Million)
TABLE 290. Russia Esomeprazole Magnesium Enteric-coated Tablets Market Size, by Route Of Admini

Companies Mentioned

  • Alkem Laboratories Ltd.
  • Amneal Pharmaceuticals LLC
  • AstraZeneca PLC
  • Aurobindo Pharma Ltd.
  • Cadila Pharmaceuticals Ltd. (Zydus Cadila)
  • Cipla Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Lupin Limited
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.

Related Topics

Related Reports

Esomeprazole - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Esomeprazole - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Esomeprazole Market - Global Forecast 2026-2032 - Product Image

Esomeprazole Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Esomeprazole Capsule Market - Global Forecast 2026-2032 - Product Image

Esomeprazole Capsule Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Esomeprazole Market Outlook 2026-2034: Market Share, and Growth Analysis by Dosage Form (Tablets, Capsules, Others), Strength, Application, Distribution Channel - Product Image

Esomeprazole Market Outlook 2026-2034: Market Share, and Growth Analysis by Dosage Form (Tablets, Capsules, Others), Strength, Application, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
Esomeprazole (CAS 119141-88-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Esomeprazole (CAS 119141-88-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.